Literature DB >> 8445714

Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant.

K R Steffy1, F Wong-Staal.   

Abstract

The envelope glycoprotein of human immunodeficiency virus type 2 (HIV-2) is primarily responsible for virus attachment and entry into the target cell population. We constructed an HIV-2 mutant virus containing an in-frame deletion within the putative CD4-binding sequences of the envelope glycoprotein and confirmed that the mutant envelope is unable to bind CD4 and that the mutant virus is noninfectious. To investigate whether this mutant could dominantly interfere with wild-type replication, we coexpressed proviral DNAs of both wild-type and mutant viruses in cells and assayed the production of infectious HIV-2 virions. Interference with virus replication was indeed observed with mutant DNA, and a maximal effect was achieved with 10-fold excess mutant DNA over wild-type DNA in the cotransfection experiments. The transdominant effect on virus replication does not appear to be at the level of wild-type envelope expression or gp120-CD4 interaction. Rather, the interference may be at the level of mixed-oligomer formation during progeny virus assembly and may occur by either destabilizing the multimeric structure of gp120 or forming a defective mixed multimeric gp120 which is unable to complete the receptor binding and/or postbinding events needed for infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445714      PMCID: PMC240249     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.

Authors:  N Hattori; F Michaels; K Fargnoli; L Marcon; R C Gallo; G Franchini
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles.

Authors:  C D Weiss; J A Levy; J M White
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  A proposal for immunotherapy of HIV seropositive healthy individuals using an HIV envelope protein devoid of CD4 binding activity.

Authors:  R Van Kuyk; P A Luciw; M B Gardner
Journal:  AIDS Res Hum Retroviruses       Date:  1990-07       Impact factor: 2.205

4.  A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.

Authors:  L Pearson; J Garcia; F Wu; N Modesti; J Nelson; R Gaynor
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function.

Authors:  M H Malim; S Böhnlein; J Hauber; B R Cullen
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

6.  Synthesis, oligomerization, and biological activity of the human immunodeficiency virus type 2 envelope glycoprotein expressed by a recombinant vaccinia virus.

Authors:  S Chakrabarti; T Mizukami; G Franchini; B Moss
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

7.  HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus.

Authors:  D Trono; M B Feinberg; D Baltimore
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

8.  A fusion-defective mutant of the vesicular stomatitis virus glycoprotein.

Authors:  M A Whitt; P Zagouras; B Crise; J K Rose
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

9.  Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  P L Earl; R W Doms; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

10.  HIV requires multiple gp120 molecules for CD4-mediated infection.

Authors:  S P Layne; M J Merges; M Dembo; J L Spouge; P L Nara
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

View more
  7 in total

1.  gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.

Authors:  P D'Aloja; E Olivetta; R Bona; F Nappi; D Pedacchia; K Pugliese; G Ferrari; P Verani; M Federico
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity.

Authors:  S S Chen; S F Lee; H J Hao; C K Chuang
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Interaction between the dominant negative mutant and the wild-type envelope proteins of Friend murine leukemia virus.

Authors:  T Matano; T Odawara; M Ohshima; A Iwamoto; H Yoshikura
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

4.  trans-dominant interference with human immunodeficiency virus type 1 replication and transmission in CD4(+) cells by an envelope double mutant.

Authors:  S S Chen; S F Lee; C K Chuang; V S Raj
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  Novel macromolecular inhibitors of human immunodeficiency virus-1 protease.

Authors:  Gabriella Miklóssy; József Tözsér; János Kádas; Rieko Ishima; John M Louis; Péter Bagossi
Journal:  Protein Eng Des Sel       Date:  2008-05-13       Impact factor: 1.650

6.  Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1.

Authors:  R Bernier; M Tremblay
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  Replicative homeostasis: a fundamental mechanism mediating selective viral replication and escape mutation.

Authors:  Richard Sallie
Journal:  Virol J       Date:  2005-02-11       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.